Attenuated Toxicity and Antitoxic Mechanism via Sodium Iodide Symporter Inhibition-Based Tumor-Selective Delivery in Astatine-211 Radioimmunotherapy.

Mol Pharm · 2026 · PMC13058875 · PMID 41764644

Europe PMC DOI

hedged sentence

0.0420

closest p · 0.8× alpha

0.0420

boldest claim

The sentences

a nonsignificant trendP = 0.042actually significant

At 18 h after administration, the %ID for the stomach contents in the 211 At-anti-HER2 mAb (ATE) group was significantly higher than in the 211 At-anti-HER2 mAb (MSB) group, accompanied by a nonsignificant trend toward higher %ID/g (%ID, P = 0.042; %ID/g, P = 0.442) ( Figure A,B). 3.5.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.